These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Couette shearing device for the investigation of shear-induced damage of the primary hemostasis by left ventricular assist devices. Lommel MA; Goubergrits L; Affeld K; Kertzscher U Int J Artif Organs; 2019 Mar; 42(3):143-150. PubMed ID: 30345868 [TBL] [Abstract][Full Text] [Related]
24. Left Ventricular Assist Device Inflow Cannula Angle and Thrombosis Risk. Chivukula VK; Beckman JA; Prisco AR; Dardas T; Lin S; Smith JW; Mokadam NA; Aliseda A; Mahr C Circ Heart Fail; 2018 Apr; 11(4):e004325. PubMed ID: 29666072 [TBL] [Abstract][Full Text] [Related]
25. Effect of rotary blood pump pulsatility on potential parameters of blood compatibility and thrombosis in inflow cannula tips. Wong KC; Büsen M; Benzinger C; Gäng R; Bezema M; Greatrex N; Schmitz-Rode T; Steinseifer U Int J Artif Organs; 2014 Dec; 37(12):875-87. PubMed ID: 25450321 [TBL] [Abstract][Full Text] [Related]
26. Reducing regional flow stasis and improving intraventricular hemodynamics with a tipless inflow cannula design: An in vitro flow visualization study using the EVAHEART LVAD. May-Newman K; Montes R; Campos J; Marquez-Maya N; Vu V; Zebrowski E; Motomura T; Benkowski R Artif Organs; 2019 Sep; 43(9):834-848. PubMed ID: 31038753 [TBL] [Abstract][Full Text] [Related]
27. Computational model of device-induced thrombosis and thromboembolism. Goodman PD; Barlow ET; Crapo PM; Mohammad SF; Solen KA Ann Biomed Eng; 2005 Jun; 33(6):780-97. PubMed ID: 16078618 [TBL] [Abstract][Full Text] [Related]
29. In vitro comparison of the hemocompatibility of two centrifugal left ventricular assist devices. Zayat R; Moza A; Grottke O; Grzanna T; Fechter T; Motomura T; Schmidt-Mewes C; Breuer T; Autschbach R; Rossaint R; Goetzenich A; Bleilevens C J Thorac Cardiovasc Surg; 2019 Feb; 157(2):591-599.e4. PubMed ID: 30414772 [TBL] [Abstract][Full Text] [Related]
30. Small Left Ventricular Size Is an Independent Risk Factor for Ventricular Assist Device Thrombosis. Chivukula VK; Beckman JA; Prisco AR; Lin S; Dardas TF; Cheng RK; Farris SD; Smith JW; Mokadam NA; Mahr C; Aliseda A ASAIO J; 2019 Feb; 65(2):152-159. PubMed ID: 29677037 [TBL] [Abstract][Full Text] [Related]
31. Shear stress evaluation on blood cells using computational fluid dynamics. Mitoh A; Suebe Y; Kashima T; Koyabu E; Sobu E; Okamoto E; Mitamura Y; Nishimura I Biomed Mater Eng; 2020; 31(3):169-178. PubMed ID: 32597794 [TBL] [Abstract][Full Text] [Related]
32. Antithrombogenicity of ventricular assist devices for postoperative myocardial dysfunction. Sato N; Miura M; Watanabe T; Suzuki Y; Hongo T; Nitta S; Mohri H; Yoda R ASAIO Trans; 1988; 34(3):290-3. PubMed ID: 3196522 [TBL] [Abstract][Full Text] [Related]
33. Device thrombosis and pre-clinical blood flow models for assessing antithrombogenic efficacy of drug-device combinations. Sukavaneshvar S Adv Drug Deliv Rev; 2017 Mar; 112():24-34. PubMed ID: 27496706 [TBL] [Abstract][Full Text] [Related]
34. Increased platelet glycoprotein IIb/IIIa activation precedes continuous-flow left ventricular assist device pump thrombosis events. Weiland M; Schuitema J; Jovinge S; Lee S Thromb Res; 2021 May; 201():143-146. PubMed ID: 33798825 [No Abstract] [Full Text] [Related]
35. Bleeding and thrombosis in chronic ventricular assist device therapy: focus on platelets. Koliopoulou A; McKellar SH; Rondina M; Selzman CH Curr Opin Cardiol; 2016 May; 31(3):299-307. PubMed ID: 27054505 [TBL] [Abstract][Full Text] [Related]
36. Science for surgeons: understanding pump thrombogenesis in continuous-flow left ventricular assist devices. de Biasi AR; Manning KB; Salemi A J Thorac Cardiovasc Surg; 2015 Mar; 149(3):667-73. PubMed ID: 25534307 [No Abstract] [Full Text] [Related]
37. Treatment of Left Ventricular Assist Device Thrombosis: Single-Center Experience. Beyazpınar DS; Ersoy Ö; Gültekin B; Aliyev A; Avsever M; Akay HT; Özkan M; Sezgin A; Aşlamacı S Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):165-167. PubMed ID: 29528019 [TBL] [Abstract][Full Text] [Related]
38. Blood trauma potential of the HeartWare Ventricular Assist Device in pediatric patients. Granegger M; Thamsen B; Schlöglhofer T; Lach S; Escher A; Haas T; Meboldt M; Schweiger M; Hübler M; Zimpfer D J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1519-1527.e1. PubMed ID: 31444074 [TBL] [Abstract][Full Text] [Related]
39. Local glycoprotein IIb/IIIa receptor inhibitor delivery from the pump surface attenuates platelet adhesion in continuous flow ventricular assist devices. Linneweber J; Dohmen PM; Kertzscher U; Affeld K; Konertz W Artif Organs; 2008 Oct; 32(10):792-9. PubMed ID: 18959668 [TBL] [Abstract][Full Text] [Related]
40. A two-phase flow approach for modeling blood stasis and estimating the thrombosis potential of a ventricular assist device. Dai WF; Wu P; Liu GM Int J Artif Organs; 2021 Jul; 44(7):471-480. PubMed ID: 33258722 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]